Mhanna Rami, Kashyap Aditya, Palazzolo Gemma, Vallmajo-Martin Queralt, Becher Jana, Möller Stephanie, Schnabelrauch Matthias, Zenobi-Wong Marcy
1 Cartilage Engineering+Regeneration, ETH Zürich , Zürich, Switzerland .
Tissue Eng Part A. 2014 May;20(9-10):1454-64. doi: 10.1089/ten.TEA.2013.0544. Epub 2014 Feb 6.
The loss of expression of chondrogenic markers during monolayer expansion remains a stumbling block for cell-based treatment of cartilage lesions. Here, we introduce sulfated alginate hydrogels as a cartilage biomimetic biomaterial that induces cell proliferation while maintaining the chondrogenic phenotype of encapsulated chondrocytes. Hydroxyl groups of alginate were converted to sulfates by incubation with sulfur trioxide-pyridine complex (SO3/pyridine), yielding a sulfated material cross-linkable with calcium chloride. Passage 3 bovine chondrocytes were encapsulated in alginate and alginate sulfate hydrogels for up to 35 days. Cell proliferation was five-fold higher in alginate sulfate compared with alginate (p=0.038). Blocking beta1 integrins in chondrocytes within alginate sulfate hydrogels significantly inhibited proliferation (p=0.002). Sulfated alginate increased the RhoA activity of chondrocytes compared with unmodified alginate, an increase that was blocked by β1 blocking antibodies (p=0.017). Expression and synthesis of type II collagen, type I collagen, and proteoglycan was not significantly affected by the encapsulation material evidenced by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and immunohistochemistry. Alginate sulfate constructs showed an opaque appearance in culture, whereas the unmodified alginate samples remained translucent. In conclusion, alginate sulfate provides a three dimensional microenvironment that promotes both chondrocyte proliferation and maintenance of the chondrogenic phenotype and represents an important advance for chondrocyte-based cartilage repair therapies providing a material in which cell expansion can be done in situ.
在单层扩增过程中软骨生成标志物表达的丧失仍然是基于细胞的软骨损伤治疗的绊脚石。在此,我们引入硫酸化海藻酸盐水凝胶作为一种软骨仿生生物材料,其可诱导细胞增殖,同时维持包封软骨细胞的软骨生成表型。通过与三氧化硫 - 吡啶络合物(SO3/吡啶)孵育,将海藻酸盐的羟基转化为硫酸盐,得到可与氯化钙交联的硫酸化材料。将第3代牛软骨细胞包封在海藻酸盐和硫酸化海藻酸盐水凝胶中长达35天。与海藻酸盐相比,硫酸化海藻酸盐中的细胞增殖高出五倍(p = 0.038)。阻断硫酸化海藻酸盐水凝胶中软骨细胞的β1整合素可显著抑制增殖(p = 0.002)。与未修饰的海藻酸盐相比,硫酸化海藻酸盐增加了软骨细胞的RhoA活性,β1阻断抗体可阻断这种增加(p = 0.017)。定量逆转录聚合酶链反应(qRT-PCR)和免疫组织化学证明,II型胶原蛋白、I型胶原蛋白和蛋白聚糖的表达和合成不受包封材料的显著影响。硫酸化海藻酸盐水凝胶构建体在培养中呈现不透明外观,而未修饰的海藻酸盐样品保持半透明。总之,硫酸化海藻酸盐提供了一种三维微环境,可促进软骨细胞增殖并维持软骨生成表型,代表了基于软骨细胞的软骨修复疗法的重要进展,提供了一种可在原位进行细胞扩增的材料。